Catalpol provides a protective effect on fibrillary Aβ1-42 -induced barrier disruption in an in vitro model of the blood-brain barrier
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Catalpol provides a protective effect on fibrillary Aβ1-42
-induced barrier disruption in an in vitro model of the blood-brain barrier
Authors
Keywords
-
Journal
PHYTOTHERAPY RESEARCH
Volume 32, Issue 6, Pages 1047-1055
Publisher
Wiley
Online
2018-02-26
DOI
10.1002/ptr.6043
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The potential mechanism for Hydroxysafflor yellow A attenuating blood-brain barrier dysfunction via tight junction signaling pathways excavated by an integrated serial affinity chromatography and shotgun proteomics analysis approach
- (2018) Yanni Lv et al. NEUROCHEMISTRY INTERNATIONAL
- Catalpol restores LPS-elicited rat microcirculation disorder by regulation of a network of signaling involving inhibition of TLR-4 and SRC
- (2016) Yun-Pei Zhang et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- High-Throughput Screening for Identification of Blood-Brain Barrier Integrity Enhancers: A Drug Repurposing Opportunity to Rectify Vascular Amyloid Toxicity
- (2016) Hisham Qosa et al. JOURNAL OF ALZHEIMERS DISEASE
- Catalpol stimulates VEGF production via the JAK2/STAT3 pathway to improve angiogenesis in rats’ stroke model
- (2016) Wan Dong et al. JOURNAL OF ETHNOPHARMACOLOGY
- 1,25-Dihydroxyvitamin D3 regulates expression of LRP1 and RAGE in vitro and in vivo, enhancing Aβ1–40 brain-to-blood efflux and peripheral uptake transport
- (2016) Y.-X. Guo et al. NEUROSCIENCE
- Amyloid β oligomers elicit mitochondrial transport defects and fragmentation in a time-dependent and pathway-specific manner
- (2016) Yanfang Rui et al. Molecular Brain
- Aβ induces PUMA activation: a new mechanism for Aβ-mediated neuronal apoptosis
- (2015) Jie Feng et al. NEUROBIOLOGY OF AGING
- The Molecular Constituents of the Blood–Brain Barrier
- (2015) Brian Wai Chow et al. TRENDS IN NEUROSCIENCES
- Oxidative and pro-inflammatory impact of regular and denicotinized cigarettes on blood brain barrier endothelial cells: is smoking reduced or nicotine-free products really safe?
- (2014) Pooja Naik et al. BMC NEUROSCIENCE
- Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease
- (2014) Shichun Tu et al. Molecular Neurodegeneration
- Blood–Brain Barrier Dysfunction as a Cause and Consequence of Alzheimer's Disease
- (2013) Michelle A Erickson et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- A 1-42-RAGE Interaction Disrupts Tight Junctions of the Blood-Brain Barrier Via Ca2+-Calcineurin Signaling
- (2012) S.-Y. Kook et al. JOURNAL OF NEUROSCIENCE
- Ischemia–reperfusion impairs blood–brain barrier function and alters tight junction protein expression in the ovine fetus
- (2012) X. Chen et al. NEUROSCIENCE
- Low-density lipoprotein receptor-related protein 1: A physiological Aβ homeostatic mechanism with multiple therapeutic opportunities
- (2012) Abhay P. Sagare et al. PHARMACOLOGY & THERAPEUTICS
- The Interaction of Amyloid β and the Receptor for Advanced Glycation Endproducts Induces Matrix Metalloproteinase-2 Expression in Brain Endothelial Cells
- (2011) Huan Du et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Insights into Caspase-Mediated Apoptotic Pathways Induced by Amyloid-ß in Cerebral Microvascular Endothelial Cells
- (2011) Silvia Fossati et al. Neurodegenerative Diseases
- Amyloid-β Contributes to Blood–Brain Barrier Leakage in Transgenic Human Amyloid Precursor Protein Mice and in Humans With Cerebral Amyloid Angiopathy
- (2011) Anika M.S. Hartz et al. STROKE
- MDR1–P-glycoprotein (ABCB1)-Mediated Disposition of Amyloid-β Peptides: Implications for the Pathogenesis and Therapy of Alzheimer’s Disease
- (2010) G Jedlitschky et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Blood-Brain-Barrier Models for the Investigation of Transporter- and Receptor-Mediated Amyloid-β Clearance in Alzheimers Disease
- (2010) T. Pflanzner et al. Current Alzheimer Research
- Amyloid β-peptide 31-35-induced neuronal apoptosis is mediated by caspase-dependent pathways via cAMP-dependent protein kinase A activation
- (2009) Li Zhao et al. AGING CELL
- Clearance of Amyloid-β Peptide Across the Blood-Brain Barrier: Implication for Therapies in Alzheimers Disease
- (2009) R. Deane et al. CNS & Neurological Disorders-Drug Targets
- Catalpol protects primary cultured cortical neurons induced by Aβ1–42 through a mitochondrial-dependent caspase pathway
- (2009) Jian Hua Liang et al. NEUROCHEMISTRY INTERNATIONAL
- Tight junctions and the modulation of barrier function in disease
- (2008) Carola Förster HISTOCHEMISTRY AND CELL BIOLOGY
- Soluble aggregates of the amyloid-β protein selectively stimulate permeability in human brain microvascular endothelial monolayers
- (2008) Francisco J. Gonzalez-Velasquez et al. JOURNAL OF NEUROCHEMISTRY
- Catalpol attenuates the neurotoxicity induced by β-amyloid1–42 in cortical neuron–glia cultures
- (2007) Bo Jiang et al. BRAIN RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search